Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A label-free electrochemical immunosensor based on Au-BSN-rGO for highly-sensitive detection of β-amyloid 1–42

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this study, a label-free electrochemical immunosensor with high sensitivity for the detection of Aβ 1–42 was constructed based on Au-BSN-rGO. It has the advantages of low detection limits, high sensitivity and a wide linear range.

          Abstract

          A label-free electrochemical immunosensor for high-sensitive detection of β-amyloid 1–42 (Aβ 1–42) was constructed based on Au-modified B, S, and N co-doped reduced graphene oxide (Au-BSN-rGO). The electronic structure of Au-BSN-rGO was investigated by first-principles calculations, which showed that the band gap of graphene was opened, thus improving its electrical conductivity. Moreover, Au-BSN-rGO was successfully prepared and characterized, and the obtained results discovered that it could be used as a signal amplifier for immunosensors due to the advantages of the good electrochemical characteristics and enormous surface area of BSN-rGO and the accelerated electron transfer ability of Au NPs. Furthermore, the label-free electrochemical immunosensor had a linear detection range of 0.1 pg mL −1–10 ng mL −1 and a detection limit of 0.072 pg mL −1, and it had good specificity, stability, and reproducibility. Also, this immunosensor showed recoveries of 89%–109% with an RSD of 2.61%–4.19% for detecting Aβ 1–42 in actual sample analysis. Therefore, the label-free electrochemical immunosensor based on Au-BSN-rGO should have a promising clinical application prospect for detecting Aβ 1–42.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Amyloid beta: structure, biology and structure-based therapeutic development

          Amyloid beta peptide (Aβ) is produced through the proteolytic processing of a transmembrane protein, amyloid precursor protein (APP), by β- and γ-secretases. Aβ accumulation in the brain is proposed to be an early toxic event in the pathogenesis of Alzheimer's disease, which is the most common form of dementia associated with plaques and tangles in the brain. Currently, it is unclear what the physiological and pathological forms of Aβ are and by what mechanism Aβ causes dementia. Moreover, there are no efficient drugs to stop or reverse the progression of Alzheimer's disease. In this paper, we review the structures, biological functions, and neurotoxicity role of Aβ. We also discuss the potential receptors that interact with Aβ and mediate Aβ intake, clearance, and metabolism. Additionally, we summarize the therapeutic developments and recent advances of different strategies for treating Alzheimer's disease. Finally, we will report on the progress in searching for novel, potentially effective agents as well as selected promising strategies for the treatment of Alzheimer's disease. These prospects include agents acting on Aβ, its receptors and tau protein, such as small molecules, vaccines and antibodies against Aβ inhibitors or modulators of β- and γ-secretase; Aβ-degrading proteases; tau protein inhibitors and vaccines; amyloid dyes and microRNAs.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            An improved Hummers method for eco-friendly synthesis of graphene oxide

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Biomarkers for neurodegenerative diseases

              Biomarkers for neurodegenerative diseases are needed to improve the diagnostic workup in the clinic but also to facilitate the development and monitoring of effective disease-modifying therapies. Positron emission tomography methods detecting amyloid-β and tau pathology in Alzheimer's disease have been increasingly used to improve the design of clinical trials and observational studies. In recent years, easily accessible and cost-effective blood-based biomarkers detecting the same Alzheimer's disease pathologies have been developed, which might revolutionize the diagnostic workup of Alzheimer's disease globally. Relevant biomarkers for α-synuclein pathology in Parkinson's disease are also emerging, as well as blood-based markers of general neurodegeneration and glial activation. This review presents an overview of the latest advances in the field of biomarkers for neurodegenerative diseases. Future directions are discussed regarding implementation of novel biomarkers in clinical practice and trials.
                Bookmark

                Author and article information

                Contributors
                Journal
                NANOHL
                Nanoscale
                Nanoscale
                Royal Society of Chemistry (RSC)
                2040-3364
                2040-3372
                February 23 2023
                2023
                : 15
                : 8
                : 4063-4070
                Affiliations
                [1 ]Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), School of Biological Engineering and Food, Hubei University of, Technology, Wuhan, 430068, PR China
                [2 ]Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan, 430068, PR China
                [3 ]National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Wuhan, 430068, PR China
                [4 ]Key Laboratory of Fermentation Engineering (Ministry of Education), Wuhan, 430068, PR China
                Article
                10.1039/D2NR05787E
                c7a81085-e58d-40d1-8b89-428f50728f0e
                © 2023

                http://rsc.li/journals-terms-of-use

                History

                Comments

                Comment on this article